Canopy Growth Corp vs iShares MSCI Malaysia ETF — how do they compare? Canopy Growth Corp trades at $1 (market cap $421.10M), while iShares MSCI Malaysia ETF trades at $28.28. The key difference: iShares MSCI Malaysia ETF is trading nearer its 52-week high, Canopy Growth Corp nearer its low. Which is the better fit depends on your goals.
| CGC | EWM | |
|---|---|---|
Market Cap | $421.10M | — |
Sector | Health | Broad Market / Factor |
52-Week High | $1.92 | $30.42 |
52-Week Low | $0.86 | $24.73 |
Enterprise Value | $378.55M | — |
Signals from Pluang's Aura AI — not financial advice
Canopy Growth (CGC) trades at $1.025, up 7.66% with bullish technical signals. The company shows improving fundamentals with Q1 2027 revenue growth of 13% and narrowing losses. Recent acquisitions and cost-cutting initiatives support expansion in medical and European cannabis markets. The stock trades below book value (P/B 0.86) while maintaining a P/S ratio of 1.71.
CGC presents a high-risk turnaround opportunity with improving balance sheet metrics and positive revenue momentum. However, persistent negative earnings and cash flow challenges require careful monitoring. Analyst sentiment remains divided with 33% buy ratings, reflecting the speculative nature of cannabis sector investments amid ongoing regulatory uncertainty.
EWM, the iShares MSCI Malaysia ETF, trades at $28.29, up 0.89% today. Technical indicators show a bearish trend with moving averages signaling sell pressure, while oscillators are neutral. The ETF is heavily weighted in Financials (54%) and Industrials (21%), positioning it to benefit from Malaysia's data center expansion and semiconductor initiatives. A dividend of $0.57 per share is scheduled for payment on June 18, 2026.
The outlook for EWM hinges on Malaysia's economic growth drivers, including tourism and energy sector developments. Risks include regional volatility and global macroeconomic pressures. Analyst sentiment is mixed, with technical weakness offset by thematic growth opportunities in Southeast Asia.
Trailing returns across standard periods
Canopy Growth, headquartered in Smiths Falls, Canada, cultivates and sells medicinal and recreational cannabis, and hemp, through a portfolio of brands that include Tweed, Spectrum Therapeutics, and CraftGrow. Although it primarily operates in Canada, Canopy has distribution and production licenses in more than a dozen countries to drive expansion in global medical cannabis and also holds an option to acquire Acreage Holdings upon U.S. federal cannabis legalization.
Read more on CGC →EWM tracks the MSCI Malaysia Index, providing exposure to the Malaysian equity market. It offers a diversified portfolio of large and mid-sized companies across various sectors in Malaysia.
Read more on EWM →